Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06279260 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

National Robotics-Assisted Radical Prostatectomy Database

Study acronym: RASOR
StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 7 more changesShow less
    • Primary completion date: Dec 2029 to Dec 2050
    • Study sites: 5 to 8
    • Study completion date: Dec 2030 to Dec 2050
    • Start date changed from estimate of Apr 2024 to Jul 1, 2024
    • Eligibility criteria shortened, about 6 words
    • Study description expanded, about 496 words
    • Collaborators: 4 to 7
  2. Minor Re-verified, no change to tracked fieldsv2
  3. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In Australia, nearly 70 men are diagnosed with Prostate cancer every day. Prostate removal (Radical Prostatectomy) is the proven treatment option to control cancer spread. Most of the prostate removal surgeries are done using robots. Robotic assisted prostate removal surgeries have been invented to minimise the risk of side effects post-surgery. Doctors prefer the robots over open surgery as there are benefits to patients (shorter hospital stays, lesser blood loss and better quality of life) and surgeons (better dexterity, improved field of vision and less pain). However, the cost of the robot outweighs the benefits at present and there is very less information concerning the long-term outcomes for patients. Studies conducted so far are small scale studies and the results from these studies cannot be generalized to the population at large in Australia. So, there is need for a largescale study that will look at the long-term outcomes and the factors that impact robotic surgeries across the metropolitan and rural hospital sectors. Hence, this comprehensive database has been setup to collaborate with major hospitals, across metropolitan and rural areas in Australia. Through this database, researchers will be able to explore the diagnostic pathway for Prostate cancer and understand the long-term benefits of robotic surgery through patient reported questionnaires. Outcomes from this database will also help compare the quality of care against other powerhouses of robotic surgery. Eventually, the database aims to standardize diagnostic pathways and clinical notes that are the same across different hospitals conducting robotic-assisted surgeries for Prostatectomy and improve care for prostate cancer patients across the country.
Trial Details
NCT Number NCT06279260
Lead Sponsor Melbourne Health
Collaborators: Peter MacCallum Cancer Centre, Australia, Epworth Healthcare, St Vincent's Hospital, Austin Health, Barwon Health, Ballarat Health Services, Western Health, Australia
Conditions
(from sponsor)
Database, Prostate Cancer, Robotic-assisted Radical Prostatectomy, Surgical Outcomes, Oncological Outcomes, Patient Reported Outcome Measures, Learning Curve
Related terms Prostatic Neoplasms
Enrollment 10,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov